(Q48004205)

7 February 2018

title

Transforming growth factor-beta isoform expression in human ovarian tumours. (English)

1 reference

7 February 2018

author name string

Bartlett JM

1

1 reference

7 February 2018

Langdon SP

2

1 reference

7 February 2018

Scott WN

3

1 reference

7 February 2018

Love SB

4

1 reference

7 February 2018

Miller EP

5

1 reference

7 February 2018

Katsaros D

6

1 reference

7 February 2018

Smyth JF

7

1 reference

7 February 2018

Miller WR

8

1 reference

7 February 2018

publication date

1 December 1997

1 reference

7 February 2018

European Journal of Cancer

published in

1 reference

7 February 2018

volume

33

1 reference

7 February 2018

page(s)

2397-2403

1 reference

7 February 2018

issue

14

1 reference

7 February 2018

Mechanism of activation of the TGF-beta receptor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Receptors for the TGF-β family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Expression of transforming growth factor beta mRNA isoforms in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Mammalian antiproliferative signals and their targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Molecular mechanisms of antiestrogen action in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

The transforming growth factor-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900304-3

7 January 2021

10.1016/S0959-8049(97)00304-3

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9616289

1 reference

7 February 2018